Internal Medicine
Meta: analysis: Interferon-γ release assays vs. tuberculin skin test for detection and management of latent tuberculosis infection
14 Jul, 2020 | 08:14h | UTC
Review: Extrapulmonary Manifestations of COVID-19
13 Jul, 2020 | 00:28h | UTCExtrapulmonary manifestations of COVID-19 – Nature Medicine
Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology
WHO Concedes Airborne Transmission of SARS-CoV-2; Critics Say Advice on Masks Still Falls Short
13 Jul, 2020 | 00:22h | UTCRelated: Transmission of SARS-CoV-2: implications for infection prevention precautions – World Health Organization AND It is Time to Address Airborne Transmission of COVID-19 – Clinical Infectious Diseases
Comprehensive Review: Face Masks and Coverings for the General Public
13 Jul, 2020 | 00:20h | UTCCommentary: Oxford COVID-19 study: face masks and coverings work – act now – University of Oxford
Editorial – Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
13 Jul, 2020 | 00:18h | UTCRelated Editorial: COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution – One Health
Updated Systematic Review: Convalescent Plasma or Hyperimmune Immunoglobulin for COVID‐19
13 Jul, 2020 | 00:13h | UTCCommentary: Convalescent plasma to treat people with COVID-19: the evidence so far – Evidently Cochrane
Related Commentary on Twitter
https://twitter.com/CochraneUK/status/1281613914296516608
Case Reports: 2 Adults with Kawasaki-like Multisystem Inflammatory Syndrome Associated with COVID-19
13 Jul, 2020 | 00:05h | UTCCase Report 1: An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19 – The Lancet
Case Report 2: An adult presentation consistent with PIMS-TS – The Lancet Rheumatology
Related Commentary on Twitter
First reports of Kawasaki-like #SARSCoV2 multi-system inflammatory syndrome in adultshttps://t.co/FYNWlxdk9q @TheLancet https://t.co/lnHMUxA7Ux @TheLancetRheum
21 yo in London, 45 yo in New York City pic.twitter.com/lLmSRzBjs4— Eric Topol (@EricTopol) July 11, 2020
Determinants of COVID-19 Disease Severity in Patients with Cancer
13 Jul, 2020 | 00:06h | UTCDeterminants of COVID-19 disease severity in patients with cancer – Nature Medicine
Commentaries: New York City data suggest link between immunotherapy, poor COVID-19 outcomes – Medwire News AND Should You Delay Cancer Treatment Because of COVID-19? Study Says Most Treatments Don’t Worsen Coronavirus Infection – Memorial Sloan Kettering
Related Commentary on Twitter
Publication of MSKCC COVID-19 experience shows that receiving ICIs seems to be associated with both increased risk of hospitalization with COVID-19 (HR 2.84; P = 0.013) and severe respiratory illness (HR 2.74; P = 0.004) https://t.co/GEU4GMVT8e
— NatureRevClinOncol (@NatRevClinOncol) July 2, 2020
Comparative Assessment of Particle Removal Efficiency of Fabric Masks as Alternatives to Standard Surgical Masks for PPE
13 Jul, 2020 | 00:07h | UTC
Related Commentary on Twitter
New @CellPressNews: Quantifying the performance of the different masks 😷 (N95, surgical, cloth)
Importance of fit and nylon overlayhttps://t.co/ZoSguWbm0X pic.twitter.com/3OAmlfRFIu— Eric Topol (@EricTopol) July 9, 2020
Observational Analysis: BCG Vaccine and COVID-19
13 Jul, 2020 | 00:02h | UTCCommentaries: Expert reaction to study looking at BCG vaccination programmes and COVID-19 deaths in different countries – Science Media Centre AND Preliminary study suggests tuberculosis vaccine may be limiting COVID-19 deaths – Virginia Tech
Podcast: Acute Kidney Injury Caused by Proton Pump Inhibitors
12 Jul, 2020 | 23:55h | UTCAcute Kidney Injury Caused by Proton Pump Inhibitors – JAMA
[Abstract Only] Randomized Trial: Intravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria
12 Jul, 2020 | 23:57h | UTCIntravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria: A Phase III Randomized Controlled Noninferiority Trial – Annals of Emergency Medicine (link to abstract – $ for full-text)
Persistent Symptoms in Patients After Acute COVID-19
10 Jul, 2020 | 09:46h | UTCPersistent Symptoms in Patients After Acute COVID-19 – JAMA
Related Commentary on Twitter
Just out: new study from @JAMA_current: of 143 patients discharged from hospital with #COVID19 (average age 56), only 13% were symptom-free an average of 2 months later. Fatigue, trouble breathing, joint pain, chest pain in >20%. https://t.co/KKwfpHnQHJ pic.twitter.com/QKRNBLeaGq
— Dr. Tom Frieden (@DrTomFrieden) July 9, 2020
Systematic Review: Signs and Symptoms to Determine if a Patient Presenting in Primary care or Hospital Outpatient Settings has COVID‐19
10 Jul, 2020 | 09:45h | UTCCommentary: Signs and symptoms of COVID-19: new Cochrane evidence – Evidently Cochrane
WHO Scientific Brief: Transmission of SARS-CoV-2: Implications for Infection Prevention Precautions
10 Jul, 2020 | 09:26h | UTCQ&A: How is COVID-19 transmitted?
Commentaries: WHO: Aerosolized Particles Unlikely To Be Significant Source Of COVID-19 Transmission – NPR AND The Coronavirus Can Be Airborne Indoors, W.H.O. Says – The New York Times
The Laboratory Diagnosis of COVID-19– Frequently-Asked Questions
10 Jul, 2020 | 09:23h | UTCThe Laboratory Diagnosis of COVID-19– Frequently-Asked Questions – Clinical Infectious Diseases
Editorial: Face Masks Can be Devastating for People with Hearing Loss
10 Jul, 2020 | 09:18h | UTCFace masks can be devastating for people with hearing loss – The BMJ
Related: Covid-19: The communication needs of D/deaf healthcare workers and patients are being forgotten – The BMJ Opinion AND D/deafness and solidarity in the covid-19 pandemic – The BMJ Opinion
Related Commentary on Twitter
"With masks covering the faces around us, we are unable to access the facial expressions and lip movements that are so vital to daily communication"
Innovation is urgently needed to ensure clear communication in medical settings https://t.co/DjQ4tmNCku
— The BMJ (@bmj_latest) July 9, 2020
Observational Study Suggests an Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors
10 Jul, 2020 | 09:19h | UTCCommentaries: Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors (PPIs) – American College of Gastroenterology AND Popular Heartburn Drugs Linked to Heightened COVID-19 Risk – TIME
A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries
10 Jul, 2020 | 09:17h | UTCVisual Abstract: Fall Injury Prevention in Older Adults
Guidelines for the Management of Diverticular Disease of the Colon
10 Jul, 2020 | 09:15h | UTC
Challenges Estimating Total Lives Lost in COVID-19 Decisions: Consideration of Mortality Related to Unemployment, Social Isolation, and Depression
9 Jul, 2020 | 09:32h | UTC
In JAMA:
"there may come a point at which the number of lives lost from economic, social, and psychological consequences of different policy decisions will outweigh the number of lives lost from infection"
What are your thoughts?https://t.co/3cQZMpFChB pic.twitter.com/2sdKPUITKP
— C. Michael Gibson MD (@CMichaelGibson) July 8, 2020
OpenSAFELY: Factors Associated with COVID-19 Death in 17 Million Patients
9 Jul, 2020 | 09:33h | UTCOpenSAFELY: factors associated with COVID-19 death in 17 million patients – Nature
Commentaries: Study of 17 Million Identifies Crucial Risk Factors for Coronavirus Deaths – The New York Times AND Expert reaction to paper from OpenSAFELY platform quantifying clinical and demographic risk factors for COVID19-related death – Science Media Centre
Related Commentary on Twitter
New @nature: the risk factors for dying from #COVID19 from >17 million people and ~11,000 deaths https://t.co/VnEs9sC2Sn @bengoldacre and colleagues
importance of age, sex, race, diabetes, obesity, many other conditions
not risk factor: hypertension; current smoker protective pic.twitter.com/xuZeHUUDXq— Eric Topol (@EricTopol) July 8, 2020
Covid-19: The Inside Story of the RECOVERY Trial
9 Jul, 2020 | 09:27h | UTCCovid-19: The inside story of the RECOVERY trial – The BMJ
Opinion: This Is Not a Normal Mental-Health Disaster
9 Jul, 2020 | 09:26h | UTCThis Is Not a Normal Mental-Health Disaster – The Atlantic
“Most people are resilient after disasters, and only a small percentage develop chronic conditions. But in a nation of 328 million, small percentages become large numbers when translated into absolute terms.”
Assessment of Patients who Tested Positive for COVID-19 After Recovery
9 Jul, 2020 | 09:23h | UTC